FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M H E Robinson

Research Profile

Procedures

Disorders

Concepts & Ideas

Geographic Areas

England

Phenomena

False Positive Reactions

Activities & Behaviors

Objects

Diet

Anatomy

Rectum

Co-author Network

Publications

TOP 3
Richard F A Logan; Georgina F Howarth; Joe West; Kate Shepherd; M H E Robinson; Jack D Hardcastle
How often is a positive faecal occult blood test the result of coeliac disease?
G F Howarth; M H E Robinson; David Jenkins; Jack D Hardcastle; Richard F A Logan
High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial.
M A Parker; M H E Robinson; John H Scholefield; Jack D Hardcastle
Psychiatric morbidity and screening for colorectal cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M H E Robinson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Richard F A Logan; Georgina F Howarth; Joe West; Kate Shepherd; M H E Robinson; Jack D Hardcastle
How often is a positive faecal occult blood test the result of coeliac disease?
European journal of gastroenterology & hepatology 2003;15(10):1097-100.
2002: G F Howarth; M H E Robinson; David Jenkins; Jack D Hardcastle; Richard F A Logan
High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial.
The American journal of gastroenterology 2002;97(3):690-4.
2002: M A Parker; M H E Robinson; John H Scholefield; Jack D Hardcastle
Psychiatric morbidity and screening for colorectal cancer.
Journal of medical screening 2002;9(1):7-10.
2001: Jonathan N Lund; John H Scholefield; Matthew J Grainge; S J Smith; CM Mangham; Nicholas Armitage; M H E Robinson; Richard F A Logan
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.
Gut 2001;49(1):91-6.
2000: M H E Robinson; VC Rodrigues; Jack D Hardcastle; J O Chamberlain; CM Mangham; Sue Moss
Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.
Journal of medical screening 2000;7(2):97-8.
1999: T J Mapp; Jack D Hardcastle; Sue Moss; M H E Robinson
Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.
The British journal of surgery 1999;86(10):1286-91.
1999: M H E Robinson; Jack D Hardcastle; Sue Moss; S S Amar; J O Chamberlain; Nicholas Armitage; John H Scholefield; CM Mangham
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.
Gut 1999;45(4):588-92.
1999: Sue Moss; Jack D Hardcastle; DA Coleman; M H E Robinson; VC Rodrigues
Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test.
International journal of epidemiology 1999;28(3):386-90.
1998: John H Scholefield; M H E Robinson; K Bostock; N S Brown
Serum ferritin. Screening test for colorectal cancer?
Diseases of the colon and rectum 1998;41(8):1029-31; discussion 1031-2.
1998: John H Scholefield; M H E Robinson; CM Mangham; Jack D Hardcastle
Screening for colorectal cancer reduces emergency admissions.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1998;24(1):47-50.
1998: M H E Robinson; Jack D Hardcastle
Should we be screening for colorectal cancer?
British medical bulletin 1998;54(4):807-21.
1997: L M Hunt; P S Rooney; K Bostock; M H E Robinson; Jack D Hardcastle; Nicholas Armitage
Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.
Gut 1997;40(1):110-2.
1996: Jack D Hardcastle; J O Chamberlain; M H E Robinson; Sue Moss; S S Amar; TW Balfour; P D James; CM Mangham
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.
Lancet 1996;348(9040):1472-7.
1996: M H E Robinson; C G Marks; P A Farrands; K Bostock; Jack D Hardcastle
Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up.
The British journal of surgery 1996;83(4):500-1.
1995: W M Thomas; J F Robertson; PG McKenna; Kim L O'Neill; M H E Robinson; Jack D Hardcastle
Serum thymidine kinase in colorectal neoplasia.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(6):632-4.
1995: M H E Robinson; C G Marks; P A Farrands; David K Whynes; K Bostock; Jack D Hardcastle
Is an immunological faecal occult blood test better than Haemoccult? A cost-benefit study.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(3):261-4.
1995: M H E Robinson; O Kronborg; C B Williams; K Bostock; P S Rooney; L M Hunt; Jack D Hardcastle
Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia.
The British journal of surgery 1995;82(3):318-20.
1995: M H E Robinson; Sue Moss; Jack D Hardcastle; David K Whynes; J O Chamberlain; CM Mangham
Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer.
Journal of medical screening 1995;2(1):41-4.
1994: M H E Robinson; G Pye; W M Thomas; Jack D Hardcastle; CM Mangham
Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1994;20(5):545-8.
1994: L M Hunt; M H E Robinson; C E Hugkulstone; B Clarke; Stephen A Vernon; R H Gregson; Jack D Hardcastle; Nicholas Armitage
Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer.
British journal of cancer 1994;70(1):173-6.
1994: David K Whynes; A R Neilson; M H E Robinson; Jack D Hardcastle
Colorectal cancer screening and quality of life.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1994;3(3):191-8.
1994: M H E Robinson; C G Marks; P A Farrands; W M Thomas; Jack D Hardcastle
Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests.
The British journal of surgery 1994;81(3):448-51.
1993: M H E Robinson; W M Thomas; Jack D Hardcastle; J Chamberlain; CM Mangham
Change towards earlier stage at presentation of colorectal cancer.
The British journal of surgery 1993;80(12):1610-2.
1993: M H E Robinson; W M Thomas; G Pye; Jack D Hardcastle; CM Mangham
Is dietary restriction always necessary in Haemoccult screening for colorectal neoplasia?
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1993;19(6):539-42.
1993: P S Rooney; Paul A Clarke; K A Gifford; M H E Robinson; Jack D Hardcastle; L G Durrant; Nicholas Armitage
Cell kinetics of the in vitro metaphase arrest technique and the clinical applications.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1993;2(5):387-92.
1993: P S Rooney; M H E Robinson; Paul A Clarke; Jack D Hardcastle; Nicholas Armitage
Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation.
The British journal of surgery 1993;80(2):249-51.
1992: Jack D Hardcastle; M H E Robinson
Screening for colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1992;28A(11):1778-80.